B. Riley Financial Faces New SEC Subpoenas Amid Ongoing Concerns

B. Riley Financial Faces New SEC Subpoenas Amid Ongoing Concerns
18 hours ago

In a recently disclosed filing, B. Riley Financial, a prominent financial services firm, has revealed that it is under scrutiny from the Securities and Exchange Commission (SEC) following the receipt of multiple subpoenas. This development has raised significant attention within the financial community, particularly as it involves the firm's founder, Bryant Riley.

Continue reading
AstraZeneca Shares Plunge Amidst Escalating Probe Concerns in China

AstraZeneca Shares Plunge Amidst Escalating Probe Concerns in China
2 months ago

AstraZeneca's stock price experienced its most significant decline in over three years, plunging sharply by 12%. This dramatic drop can be attributed to escalating fears surrounding a regulatory investigation in China involving the pharmaceutical giant. Investors reacted swiftly to the news, indicating a growing concern over potential implications for AstraZeneca’s operations and revenue in one of the world’s largest pharmaceutical markets.

Continue reading